Cost Benefit Analyses versus Referenda

immunization against haemophilus influenzae type b in iran; cost‑utility and cost‑benefit analyses

in children. although its burden is considerably preventable by vaccine, routine vaccination against hib has not been defined in the national immunization program of iran. this study was performed to assess the cost-benefit and cost‑utility of running an hib vaccination program in iran. methods: based on a previous systematic review and meta‑analysis for vaccine efficacy, we estimated the avert...

Drug-eluting stents: cost versus clinical benefit.

The publication in January 2001 of the first-in-man results showing zero restenosis after sirolimus-eluting stent implantation produced enormous excitement in the cardiological community.1 The long-awaited tool—a safe, restenosis-proof, easy-to-use stent—had been found. It was not too long thereafter that paclitaxel-eluting stents also demonstrated their capability to decrease restenosis. Today...

Risk assessment and cost-benefit analyses: in the public interest?

'Department of Biology and Biochemistry, Brunel University, Kingston Lane, Uxbridge, Middlesex UB8 3PH; 2Istituto di Ginecologia e Ostetricia, Universita di Torino, Turin, Italy; 3Constultant Obstetrics and Gynaecology, Queen's Medical Centre, Clifton Bullevard, Nottingham, NG7 2UH; 4The Health Centre, Torrington Park, London N12 9SS; 'University College and Middlesex School of Medicine, Windey...

Using Cost Benefit Analyses to Develop SPI Strategies

Control of Echinococcus multilocularis: strategies, feasibility and cost-benefit analyses.

Echinococcus multilocularis, the zoonotic agent of human alveolar echinococcosis, has considerably extended its range and became more prevalent in many parts of the endemic areas. Accordingly, there is an increasing demand for measures to prevent human infections. Rising public awareness of this zoonosis and individual protective actions should be part of every prevention program. Considering t...